CARLSON DNA Sequencing
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Food and Drug Administration is forecasting a procurement for Carlson DNA Sequencing services focused on microbiome analysis, targeting the NAICS code 541714 for other research and development in the physical, engineering, and life sciences. The opportunity is posted under the CBER acquisition unit, with the program point of contact listed as Cber Acquisitions Liaison at cberacquisitions@fda.hhs.gov, though the contracting officer designation remains pending. The service will involve advanced DNA sequencing capabilities to support scientific evaluation and regulatory functions related to microbiome research, likely for applications in product safety, efficacy, or biological characterization. While the place of performance and set-aside details are not specified, the forecast indicates an upcoming formal solicitation, and potential vendors should prepare for competitive bidding under federal acquisition guidelines.
General Info
Agency
NAICS
Place of Performance
USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Food and Drug Administration → Food And Drug Administration
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
